Astellas Pharma (4503) stock
Astellas Pharma technical analysis
Oscillators
Summary
Moving averages
| Oscillators | Value | Signal |
|---|---|---|
| RSI (14) | 41.68 | Neutral |
| Stochastic %K (14, 3, 3) | 21.28 | Neutral |
| CCI (20) | -99.75 | Neutral |
| ADX (14) | 16.33 | Neutral |
| Awesome Oscillator | -65.95 | Sell |
| Momentum (10) | -121.5 | Sell |
| MACD (12, 26) | -13.62 | Sell |
| Stoch RSI (3, 3, 14, 14) | 6.274 | Neutral |
| Williams %R (14) | -86.04 | Neutral |
| Bull Bear Power | -131.58 | Neutral |
| Ultimate Oscillator (7, 14, 28) | 47.76 | Neutral |
| Moving averages | Value | Signal |
|---|---|---|
| EMA (10) | ¥2,289.66 | Sell |
| SMA (10) | ¥2,314.40 | Sell |
| EMA (20) | ¥2,306.60 | Sell |
| SMA (20) | ¥2,303.68 | Sell |
| EMA (30) | ¥2,308.29 | Sell |
| SMA (30) | ¥2,335.22 | Sell |
| EMA (50) | ¥2,300.09 | Sell |
| SMA (50) | ¥2,309.65 | Sell |
| EMA (100) | ¥2,281.94 | Sell |
| SMA (100) | ¥2,247.06 | Sell |
| EMA (200) | ¥2,205.53 | Buy |
| SMA (200) | ¥2,300.14 | Sell |
| Ichimoku Base Line (9, 26, 52, 26) | ¥2,306.50 | Sell |
| VWMA (20) | ¥2,307.21 | Sell |
| Hull MA (9) | ¥2,224.95 | Buy |
Support & resistance levels
Resistance
- R3¥2,455.00+9.43%Weak
- R2¥2,398.07+6.89%Strong
- R1¥2,313.41+3.12%Moderate
Support
- S1¥2,133.99-4.88%Strong
- S2¥2,041.00-9.03%Weak
- S3¥1,938.50-13.59%Weak
Levels are detected automatically from swing highs and lows on the daily chart and clustered by volatility (ATR). Strength reflects the number of times price reacted at each level.
| Pivot points (daily) | S3 | S2 | S1 | P | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | ¥2,196.83 | ¥2,209.67 | ¥2,222.33 | ¥2,235.17 | ¥2,247.83 | ¥2,260.67 | ¥2,273.33 |
| Fibonacci | ¥2,209.67 | ¥2,219.41 | ¥2,225.43 | ¥2,235.17 | ¥2,244.91 | ¥2,250.93 | ¥2,260.67 |
| Camarilla | ¥2,227.99 | ¥2,230.33 | ¥2,232.66 | ¥2,235.17 | ¥2,237.34 | ¥2,239.68 | ¥2,242.01 |
| Woodie | ¥2,196.75 | ¥2,209.63 | ¥2,222.25 | ¥2,235.13 | ¥2,247.75 | ¥2,260.63 | ¥2,273.25 |
| DeMark | — | — | ¥2,216.00 | ¥2,232.00 | ¥2,241.50 | — | — |
Astellas Pharma price forecast
| Horizon | Bear case (95%) | Low (68%) | Trend target | High (68%) | Bull case (95%) |
|---|---|---|---|---|---|
| 5 trading days | ¥2,072.52 | ¥2,160.09 | ¥2,251.35 +0.4% | ¥2,346.47 | ¥2,445.61 |
| 21 trading days | ¥1,921.48 | ¥2,091.54 | ¥2,276.66 +1.5% | ¥2,478.17 | ¥2,697.51 |
| 63 trading days | ¥1,747.65 | ¥2,024.18 | ¥2,344.47 +4.5% | ¥2,715.44 | ¥3,145.11 |
The technical bias for Astellas Pharma is bearish (overall rating: Strong Sell).
Bullish scenario: a sustained break above ¥2,313.41 would open the way toward ¥2,398.07.
Bearish scenario: a daily close below ¥2,133.99 could extend the decline toward ¥2,041.00.
Statistical ranges are based on historical volatility and trend, not a guarantee of future prices. Not financial advice.
About Astellas Pharma
Astellas Pharma (4503) shares are trading at ¥2,243.50, up +0.38% today. The company belongs to the Other sector and has a market capitalization of ¥4.02T.
The stock’s 52-week range is ¥1,557.50 – ¥2,717.00, with a price-to-earnings ratio of 13.8. It has moved -5.26% over the past week and -4.36% over the past month.
On the daily chart the overall technical rating for Astellas Pharma is Strong Sell, with the 14-day RSI at 41.7. The nearest support is at ¥2,133.99 and the nearest resistance at ¥2,313.41.
Related markets
AllStock market news
-
Trump waives rules on red-dyed diesel, but local tax and other concerns remainMarketWatch.com36 min. ago
-
JPMorgan reveals stocks worth buying in October 2026Yahoo Finance37 min. ago
-
Q2 Rundown: GE Vernova (NYSE:GEV) Vs Other Electrical Systems StocksYahoo Finance37 min. ago
-
3 Growth Stocks to Buy Instead of SpaceXYahoo Finance60 min. ago
-
U.S. stocks rise toward an all-time high after oil prices easePittsburgh Post-Gazette1 hr. ago
-
‘Trump accounts’ could force MAGA children to own New York Times stockMarketWatch.com1 hr. ago